anti-inflammatory therapy chronic disease: challenges opportunities
number widespread devastating chronic diseases including atherosclerosis type diabetes alzheimers disease pathophysiologically important inflammatory component diseases precise identity inflammatory stimulus often unknown known difficult remove thus interest therapeutically targeting inflammatory response although success anti-inflammatory therapy chronic diseases triggered primary inflammation dysregulation autoimmunity considerable limitations particular inflammatory response critical survival result redundancy compensatory pathways necessity narrow risk: benefit ratio anti-inflammatory drugs however new advances understanding inflammatory signaling links resolution pathways together new drug development offer promise area translational biomedical research
